Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies
- 5 December 2018
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (1) , 227-232
Abstract
Significance: Due to difficulty in obtaining relevant samples and low levels of dengue virus (DENV) present in patients, it has been difficult to characterize the properties of virions circulating in humans. We characterized DENV1 directly from early acute primary dengue samples and from their cell culture isolates. We observed that virions in humans are more infectious and mature as compared with their cell culture isolates. DENV1 cell culture isolates were hypersensitive to neutralization by human antibodies. Cross-reactive fusion loop antibodies and heterotypic immune sera poorly neutralized plasma DENV1. Identical genome sequences showed that the phenotypic differences are due to the differences in maturation state. The observed structural variation is a significant advance applicable to understanding vaccine failure and designing future vaccine strategies.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (1-R01-AI107731-01)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (P01 AI106695)
- UNC virology training grant (T32AI007419)
- Minority Student Development grant (5R25GM055336)
This publication has 30 references indexed in Scilit:
- The Battle between Infection and Host Immune Responses of Dengue Virus and Its Implication in Dengue Disease PathogenesisThe Scientific World Journal, 2013
- Role of CD61+ cells in thrombocytopenia of dengue patientsInternational Journal of Hematology, 2012
- Identification of human neutralizing antibodies that bind to complex epitopes on dengue virionsProceedings of the National Academy of Sciences, 2012
- Degrees of maturity: the complex structure and biology of flavivirusesCurrent Opinion in Virology, 2012
- Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein ProtectIn Vivovia Fcγ Receptor and Complement-Dependent Effector MechanismsJournal of Virology, 2011
- Partial maturation: an immune-evasion strategy of dengue virus?Trends in Microbiology, 2011
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing ActivityCell Host & Microbe, 2010
- Association of the pr Peptides with Dengue Virus at Acidic pH Blocks Membrane FusionJournal of Virology, 2009
- Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccineVaccine, 2006
- Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2–3 September, 2004Vaccine, 2005